The Mexico Compounding Pharmacies Market was valued at USD 134.89 million in 2024, and is projected to reach USD 181.12 million by 2030, rising at a CAGR of 5.02%. The increasing demand for personalized medicine is driven by the need to enhance treatment effectiveness, safety, and efficiency. The growing prevalence of chronic conditions, such as diabetes, cardiovascular diseases, and neurological disorders, is fueling the demand for customized formulations. Furthermore, compounding pharmacies are essential in improving medication adherence by addressing individual patient needs, including allergies, taste preferences, and dosage modifications. Therefore, the answer is: The increasing demand for personalized medicine, driven by the need for customized formulations and improved medication adherence, is propelling market growth.
The increasing accessibility of genetic testing and molecular profiling across the country allows healthcare professionals to tailor medications based on a patient’s genetic makeup. For instance, a July 2021 article in the World Journal of Oncology titled “Personalized Medicine in Ovarian Cancer: A Perspective from Mexico” highlighted how researchers identified molecular factors involved in the pathogenesis of ovarian cancer. This discovery enables patients to receive personalized diagnoses and assists healthcare providers in predicting effective treatments for the disease, ultimately improving the efficiency, cost-effectiveness, safety, and outcomes of healthcare.
Moreover, nutritional deficiencies in the population present lucrative growth opportunities for compounding pharmacies. According to the World Health Organization (WHO), nutritional deficiencies were responsible for 10,726 deaths in Mexico in 2021. Data from the National Health and Nutrition Survey 2021 reported alarming rates of overweight and obesity, affecting 37.4% of children (5-11 years old), 42.9% of adolescents (12-19 years old), and 72.4% of adults (20 years and older).
The increasing accessibility of genetic testing and molecular profiling across the country allows healthcare professionals to tailor medications based on a patient’s genetic makeup. For instance, a July 2021 article in the World Journal of Oncology titled “Personalized Medicine in Ovarian Cancer: A Perspective from Mexico” highlighted how researchers identified molecular factors involved in the pathogenesis of ovarian cancer. This discovery enables patients to receive personalized diagnoses and assists healthcare providers in predicting effective treatments for the disease, ultimately improving the efficiency, cost-effectiveness, safety, and outcomes of healthcare.
Moreover, nutritional deficiencies in the population present lucrative growth opportunities for compounding pharmacies. According to the World Health Organization (WHO), nutritional deficiencies were responsible for 10,726 deaths in Mexico in 2021. Data from the National Health and Nutrition Survey 2021 reported alarming rates of overweight and obesity, affecting 37.4% of children (5-11 years old), 42.9% of adolescents (12-19 years old), and 72.4% of adults (20 years and older).
Mexico Compounding Pharmacies Market Report Highlights
- On the basis of therapeutic area, the pain management segment held the largest market share in 2024. This can be attributed to the offering of customized medications tailored to the specific needs of individual patients.
- On the basis of age cohort, the adult segment held the largest revenue share in 2024 due to the rising shift from reactive to preventive medicine.
- On the basis of type, Pharmaceutical Ingredient Alteration (PIA) segment held the largest market share in 2024. This can be attributed to its quick response to shortages of certain medicines by reformulating available ingredients into effective alternatives.
- On the basis of sterility, the sterile segment held the largest market share in 2024. This can be attributed to the rise in chronic diseases, healthcare and the aging population.
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
- COVID-19's impact and how to sustain in this fast-evolving market.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. Therapeutic Area Business Analysis
Chapter 5. Age Cohort Business Analysis
Chapter 6. Type Business Analysis
Chapter 7. Sterility Business Analysis
Chapter 8. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this Mexico Compounding Pharmacies market report include:- Fagron (Brands & Essentials)
- Omicronlab
- Magistral Pharmacies
- BIOH
- FarmaLife
- Farmacia México
- Pharma Tycsa
- Compounding Wholesalers de México
- MXPharmacy (Edge Pharma)
- Farmacias el Globo
- DermiCo
- Bionorusso
- Hervanario
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | February 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 134.89 Million |
| Forecasted Market Value ( USD | $ 181.12 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Mexico |
| No. of Companies Mentioned | 14 |
